BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 167.87 |
| Open | 168.09 |
| Bid | 163.08 x 900 |
| Ask | 163.31 x 800 |
| Day's range | 159.91 - 169.26 |
| 52-week range | 121.32 - 464.00 |
| Volume | |
| Avg. volume | 1,583,250 |
| Market cap | 39.53B |
| Beta (5Y monthly) | -0.70 |
| PE ratio (TTM) | 5.17 |
| EPS (TTM) | 31.54 |
| Earnings date | 09 Nov 2021 |
| Forward dividend & yield | 2.11 (1.33%) |
| Ex-dividend date | 02 Jun 2022 |
| 1y target est | 320.42 |
- Zacks
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
AstraZeneca's (AZN) third/booster dose of its COVID-19 vaccine gets authorized in Europe for use in adults, both for homologous and heterologous use.
- Zacks
Ocugen (OCGN) Covaxin Studies Clinical Hold Lifted by FDA
Ocugen (OCGN) gets respite after the FDA lifts the clinical hold on the company's phase II/III study, OCU-002, for Covaxin (BBV152).
- Zacks
Pfizer & BioNTech COVID Jab Booster Effective in Kids Under 5
Pfizer (PFE) and BioNTech (BNTX) state that their three-dose COVID-19 vaccine is 80% effective in children under five years of age.
© 2022 Yahoo. All rights reserved.
